NCT07301268 2026-02-03GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 AstrocytomaMayo ClinicPhase 2 Suspended36 enrolled